CD96 and neoplasm: Interestingly, the combination of CD96‐blocking antibody and docetaxel significantly reduced tumor growth in models with MCF‐7 BCSCs expressing high levels of CD96 (Figures 4F and Figure S3C, Supporting Information), with limited tumor growth in MCF‐7 cells expressing low levels of CD96 (Figure S3D, Supporting Information).